Estrella Immunopharma, Inc. Quarterly General and Administrative Expense in USD from Q3 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Estrella Immunopharma, Inc. quarterly General and Administrative Expense history and growth rate from Q3 2022 to Q1 2024.
  • Estrella Immunopharma, Inc. General and Administrative Expense for the quarter ending March 31, 2024 was $445K, a 278% increase year-over-year.
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $445K +$327K +278% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $945K +$797K +537% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $1.39M +$1.11M +395% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q1 2023 $118K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $148K Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 $280K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.